Genmab A/S and Merus N.V. announced that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company with its late-stage breakthrough therapy asset petosemtamab, which is in
SayVo AI has unveiled the next evolution of its AI-powered sales representatives, now delivering enterprise-grade scalability and seamless integration into modern sales pipelines. Built to mirror the strengths of a client’s ideal employee, these AI reps engage leads, handle objections,
NiCE announced the appointment of Jeff Comstock as President, CX Product & Technology, effective October 1, 2025. Comstock will report directly to NiCE Chief Executive Officer Scott Russell and will join the company’s Executive Leadership Team. Comstock joins NiCE following a distinguished 25-year
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
